Cargando…

Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic

During the first months of the coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), cases of human‐to‐cat transmission were reported. Seroconversion was shown in cats infected under experimental and natural conditions. This large‐scale surve...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Julia Maria, Weber, Corinna, Wernike, Kerstin, Michelitsch, Anna, Friedrich, Karin, Trimpert, Jakob, Beer, Martin, Kohn, Barbara, Osterrieder, Klaus, Müller, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115359/
https://www.ncbi.nlm.nih.gov/pubmed/35238485
http://dx.doi.org/10.1111/zph.12932
_version_ 1784709923733504000
author Adler, Julia Maria
Weber, Corinna
Wernike, Kerstin
Michelitsch, Anna
Friedrich, Karin
Trimpert, Jakob
Beer, Martin
Kohn, Barbara
Osterrieder, Klaus
Müller, Elisabeth
author_facet Adler, Julia Maria
Weber, Corinna
Wernike, Kerstin
Michelitsch, Anna
Friedrich, Karin
Trimpert, Jakob
Beer, Martin
Kohn, Barbara
Osterrieder, Klaus
Müller, Elisabeth
author_sort Adler, Julia Maria
collection PubMed
description During the first months of the coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), cases of human‐to‐cat transmission were reported. Seroconversion was shown in cats infected under experimental and natural conditions. This large‐scale survey of 1,005 serum samples was conducted to investigate anti‐SARS‐CoV‐2 antibody prevalence in domestic cats during the first 7 months of the pandemic in Germany and other European countries. In addition, we compared the sensitivity and specificity of two multispecies SARS‐CoV‐2 antibody enzyme‐linked immunosorbent assays (ELISA). Results were confirmed by using an indirect immunofluorescence test (iIFT) and a surrogate virus neutralization test (sVNT). Sera that were highly positive for feline coronavirus (FCoV) antibodies (n = 103) were included to correct for cross‐reactivity of the tests used. Our results showed an overall SARS‐CoV‐2 seropositivity of 1.9% (n = 19) in a receptor‐binding domain (RBD)‐based ELISA, additional 0.8% (n = 8) were giving inconclusive results. In contrast, a nucleocapsid‐based ELISA revealed 0.5% (n = 5) positive and 0.2% (n = 2) inconclusive results. While the iIFT and sVNT confirmed 100% of positive and 50%–57.1% of the doubtful results as determined in the RBD ELISA, the nucleocapsid‐based assay showed a high discrepancy and only one of the five positive results could be confirmed. The results indicate significant deficits of the nucleocapsid‐based ELISA with respect to sensitivity and specificity. Due to a significantly higher rate (5.8%) of positive results in the group of highly FCoV antibody‐positive samples, cross‐reactivity of the FCoV‐ELISA with SARS‐CoV‐2 antibodies cannot be excluded. Furthermore, we investigated the impact of direct contact of domestic cats (n = 23) to SARS‐CoV‐2 positive owners. Considering one inconclusive result, which got confirmed by iIFT, this exposure did not lead to a significantly higher prevalence (4.4%; p = .358) among tested subjects. Overall, we conclude that cats are a negligible entity with respect to virus transmission in Europe.
format Online
Article
Text
id pubmed-9115359
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91153592022-05-18 Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic Adler, Julia Maria Weber, Corinna Wernike, Kerstin Michelitsch, Anna Friedrich, Karin Trimpert, Jakob Beer, Martin Kohn, Barbara Osterrieder, Klaus Müller, Elisabeth Zoonoses Public Health Original Articles During the first months of the coronavirus disease (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), cases of human‐to‐cat transmission were reported. Seroconversion was shown in cats infected under experimental and natural conditions. This large‐scale survey of 1,005 serum samples was conducted to investigate anti‐SARS‐CoV‐2 antibody prevalence in domestic cats during the first 7 months of the pandemic in Germany and other European countries. In addition, we compared the sensitivity and specificity of two multispecies SARS‐CoV‐2 antibody enzyme‐linked immunosorbent assays (ELISA). Results were confirmed by using an indirect immunofluorescence test (iIFT) and a surrogate virus neutralization test (sVNT). Sera that were highly positive for feline coronavirus (FCoV) antibodies (n = 103) were included to correct for cross‐reactivity of the tests used. Our results showed an overall SARS‐CoV‐2 seropositivity of 1.9% (n = 19) in a receptor‐binding domain (RBD)‐based ELISA, additional 0.8% (n = 8) were giving inconclusive results. In contrast, a nucleocapsid‐based ELISA revealed 0.5% (n = 5) positive and 0.2% (n = 2) inconclusive results. While the iIFT and sVNT confirmed 100% of positive and 50%–57.1% of the doubtful results as determined in the RBD ELISA, the nucleocapsid‐based assay showed a high discrepancy and only one of the five positive results could be confirmed. The results indicate significant deficits of the nucleocapsid‐based ELISA with respect to sensitivity and specificity. Due to a significantly higher rate (5.8%) of positive results in the group of highly FCoV antibody‐positive samples, cross‐reactivity of the FCoV‐ELISA with SARS‐CoV‐2 antibodies cannot be excluded. Furthermore, we investigated the impact of direct contact of domestic cats (n = 23) to SARS‐CoV‐2 positive owners. Considering one inconclusive result, which got confirmed by iIFT, this exposure did not lead to a significantly higher prevalence (4.4%; p = .358) among tested subjects. Overall, we conclude that cats are a negligible entity with respect to virus transmission in Europe. John Wiley and Sons Inc. 2022-03-02 2022-08 /pmc/articles/PMC9115359/ /pubmed/35238485 http://dx.doi.org/10.1111/zph.12932 Text en © 2022 The Authors. Zoonoses and Public Health published by Wiley‐VCH GmbH. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Adler, Julia Maria
Weber, Corinna
Wernike, Kerstin
Michelitsch, Anna
Friedrich, Karin
Trimpert, Jakob
Beer, Martin
Kohn, Barbara
Osterrieder, Klaus
Müller, Elisabeth
Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic
title Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic
title_full Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic
title_fullStr Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic
title_full_unstemmed Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic
title_short Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic
title_sort prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in germany and other european countries in the early phase of the coronavirus disease‐19 pandemic
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115359/
https://www.ncbi.nlm.nih.gov/pubmed/35238485
http://dx.doi.org/10.1111/zph.12932
work_keys_str_mv AT adlerjuliamaria prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT webercorinna prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT wernikekerstin prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT michelitschanna prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT friedrichkarin prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT trimpertjakob prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT beermartin prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT kohnbarbara prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT osterriederklaus prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic
AT mullerelisabeth prevalenceofantisevereacuterespiratorysyndromecoronavirus2antibodiesincatsingermanyandothereuropeancountriesintheearlyphaseofthecoronavirusdisease19pandemic